Digital Health Investors & VC Firms in New York
126 firms in this list, with a median first check of $500K. 35 of them lead rounds. Generated from verified public data and updated continuously.
Oxeon Partners
New YorkSeed–Late Stage
52 people
PeakSpan Capital Partners
New YorkSeries A–Growth$3M – $50M
36 people
AIF
New YorkSeed–Growth
39 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
15 people
Female Founders
New YorkSeed$750K – $1M
9 people
StartUp Health
New YorkSeed
38 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
Black Angel Group
New YorkSeed–Series A
38 people
Aegis Ventures
New YorkSeed–Series A
35 people
Digitalis Ventures
New YorkSeed–Late Stage$100K – $10M
15 people
Black Opal Ventures
New YorkSeed–Late Stage
28 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
30 people
Signet Healthcare Partners
New YorkGrowth–Late Stage$10M – $50M
13 people
Catalyst Investors
New YorkSeries A–Growth$10M – $20M
20 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
17 people
Connectivity Ventures
New YorkPre-Seed–Seed
26 people
Primetime Partners
New YorkSeed–Series A$250K – $1M
13 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Able Partners
New YorkPre-Seed–Series A$500K – $3M
3 people
Oberland Capital
New YorkGrowth–Late Stage$50M – $300M
20 people
Rocana Ventures
New YorkSeed–Series A$1M – $30M
15 people
Adjuvant Capital
New YorkSeries A–Late Stage$10M – $25M
19 people
Ansa Capital
New YorkSeries A–Series B$5M – $15M
6 people
Medical Excellence Capital
New YorkPre-Seed–Series B
21 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.










































































































